SINOPHARM GROUP LTD Stock Math Operators Price Series Multiplication

SHTDY Stock  USD 13.20  -0.19  -1.42%   
The math operators module provides an execution environment for Price Series Multiplication operator and related indicators on SINOPHARM GROUP and ConvaTec Group Plc. This view tracks relative price relationships between SINOPHARM GROUP and ConvaTec Group Plc to support structured performance interpretation without implying advice.

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. SINOPHARM GROUP LTD Price Series Multiplication is a cross multiplication of SINOPHARM GROUP price series and its benchmark/peer.

SINOPHARM GROUP Technical Analysis Modules

Most technical analysis of SINOPHARM GROUP help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for SINOPHARM from various momentum indicators to cycle indicators. When you analyze SINOPHARM charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About SINOPHARM GROUP CO LTD ADR

Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm is traded on OTC Exchange in the United States. A high-level view of SINOPHARM GROUP emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/E of 6.27, P/B of 0.9, profit margin of 1.45%. SINOPHARM GROUP has a market cap of 8.61 B, P/E of 6.27, ROE of 13.19%.

Methodology

Unless otherwise specified, financial data for SINOPHARM GROUP LTD is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. SINOPHARM (USA Stocks:SHTDY) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

SINOPHARM GROUP LTD may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.


Become your own money manager

Tracking SINOPHARM GROUP inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Hedge Favorites Idea
Hedge Favorites
Invested over 20 shares
Dividend Beast Idea
Dividend Beast
Invested over 40 shares
Impulse Idea
Impulse
Invested over 200 shares
Cash Cows Idea
Cash Cows
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Marketing Idea
Marketing
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 20 shares
Momentum Idea
Momentum
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares

More Resources for SINOPHARM Pink Sheet Analysis

Other Information on Investing in SINOPHARM Pink Sheet

SINOPHARM GROUP financial ratios help frame valuation context across profits, cash flow, and enterprise value. They help compare SINOPHARM across valuation measures.